Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia

Br J Haematol. 2020 Oct;191(1):123-126. doi: 10.1111/bjh.16949. Epub 2020 Jul 9.

Georgina L Ryland^{1

2

3}, Allison Barraclough⁴, Chun Yew Fong^{4

5}, Shaun Fleming⁶, Ashish Bajel⁷, Oliver Hofmann², David Westerman^{1

3

7}, Sean Grimmond², Piers Blombery^{1

3

7}

¹ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
² Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
⁴ Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia.
⁵ Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
⁶ Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.
⁷ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.

No abstract available

Publication types